Cureverse

Operator of a pharmaceutical research and development company intended for the treatment of brain diseases and multiple sclerosis. The company develops small-molecule drugs for Alzheimer's and Parkins...

Healthcare

Seoul, South Korea

Founded 2021

7 employees

Website

Valuation

Share Price

N/A

Total Raised

$77.3M

Last Round

N/A

Investors

+12 other investors

View all 12 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock Cureverse's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required